Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Breaking News: China Jails British-US Investigator Couple

August 8, 2014 1:50 pm | News | Comments

A Briton and an American were sentenced to prison on Friday on charges of illegally trading in the personal details of Chinese citizens after they testified they bought such information to help companies combat fraud and acknowledged having obtained personal details about Chinese nationals. Read more...

TOPICS:

3SBio, DiNonA Partner on Leukemia mAb

August 8, 2014 10:46 am | News | Comments

3SBio Inc. announced it has entered into an exclusive license with DiNonA Inc. for the development, manufacturing and marketing of Leukotuximab, an anti JL-1 antibody for acute leukemia, including acute myelocytic leukemia and acute lymphoblastic leukemia, in the territory of Greater China and the Middle East. Read more...

TOPICS:

EMA Accepts Application for New Pneumococcal Vaccine Indication

August 8, 2014 10:41 am | News | Comments

Pfizer Inc. announced that the European Medicines Agency has accepted Pfizer’s application seeking to expand the indication for Prevenar 13 in adults to include the prevention of pneumonia caused by the 13 pneumococcal serotypes contained in the vaccine. Read more...

TOPICS:
Advertisement

Charity, Industry Join Forces on Pancreatic Cancer Drugs

August 8, 2014 10:35 am | News | Comments

Cancer Research UK and its commercial arm, Cancer Research Technology, are to join forces with Astellas Pharma Inc. to find new drug targets in the fight against cancer, with an initial focus on pancreatic cancer, one of the deadliest forms of cancer. Read more...

TOPICS:

British, US Couple Testify in Chinese Trial

August 8, 2014 10:28 am | News | Comments

A Briton and an American charged with illegally trading in the personal details of Chinese nationals testified Friday that they bought such information to help companies combat fraud under contract for British pharmaceutical giant GlaxoSmithKline, which is accused in a separate case of bribing Chinese doctors and hospitals to use its products. Read more...

TOPICS:

Splicing Modifiers May Correct Spinal Muscular Atrophy Deficit

August 8, 2014 10:03 am | News | Comments

The journal Science published results of a preclinical study demonstrating that treatment with orally available RNA splicing modifiers of the SMN2 gene starting early after birth is preventing deficits in mouse models of Spinal Muscular Atrophy. Read more...

TOPICS:

FDA Lifts Hold on Tekmira’s Experimental Ebola Drug

August 8, 2014 9:55 am | by Matthew Perrone, AP Health Writer | News | Comments

U.S. health authorities have eased safety restrictions on an experimental drug to treat Ebola, a move that could clear the way for its use in patients infected with the deadly virus, prompting praise by Tekmira's CEO Mark Murray on Thursday. Read more...

TOPICS:

Breath Reveals Hidden Image in Anti-Counterfeit Labels

August 7, 2014 1:00 pm | Videos | Comments

Counterfeit drugs, which at best contain wrong doses and at worst are toxic, are thought to kill more than 700,000 people per year. To fight back against counterfeiting, researchers have developed a way to make labels that change when you breathe on them, revealing a hidden image. Read more...

TOPICS:
Advertisement

Cure to Lung Cancer May Depend on Your DNA

August 7, 2014 1:00 pm | News | Comments

The Northside Hospital Cancer Institute announced its participation in a unique National Cancer Institute clinical collaboration to treat lung cancer based on a person’s genetic makeup. Read more...               

TOPICS:

FDA Approves Orbactiv to Treat Skin Infections

August 7, 2014 1:00 pm | News | Comments

The FDA approved Orbactiv (oritavancin), a new antibacterial drug to treat adults with skin infections, including Staphylococcus aureus, various Streptococcus species and Enterococcus faecalis. Read more...         

TOPICS:

Ethical Issue: Who Gets Experimental Ebola Drug?

August 7, 2014 1:00 pm | News | Comments

The use of an experimental drug to treat two Americans diagnosed with Ebola is raising ethical questions about who gets first access to unproven new therapies for the deadly disease. Read more...                

TOPICS:

Mylan Profit Drops 30% in Q2

August 7, 2014 1:00 pm | News | Comments

Mylan Inc. on Thursday reported profit that declined by 30 percent in its second quarter, and missed analysts' expectations. The Canonsburg, Pennsylvania-based company said net income fell to $125.2 million. Read more...       

TOPICS:

Takeda to Extend Global Reach

August 7, 2014 1:00 pm | News | Comments

New Takeda Pharmaceutical Co. President Christophe Weber said recently that Japan's biggest drugmaker will continue efforts to expand its business abroad through acquisitions and will outline a new strategy by the end of the year. Read more...  

TOPICS:

Study Correlates Immune Response, Improved Survival in Prostate Cancer

August 7, 2014 10:58 am | News | Comments

Generex Biotechnology Corp. announced publication of a follow-up study from a Phase 1 clinical trial of the immunotherapeutic agent AE37 in patients with prostate cancer that demonstrates an association between a specific immune response generated by AE37 and improved overall survival. Read more...

TOPICS:

Last Patient Completes Oramed Oral Insulin Trial

August 7, 2014 10:52 am | News | Comments

Oramed Pharmaceuticals Inc. reported that the last patient has completed treatment in its Phase 2a clinical trial of ORMD-0801, the company's proprietary oral insulin capsule, to treat type 1 diabetes, and top-line data is expected to be reported in the fourth quarter of 2014. Read more...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading